TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia

Kevin G. Burfeind, Xinxia Zhu, Peter R. Levasseur, Katherine A. Michaelis, Mason A. Norgard, Daniel Marks

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hypothalamic inflammation is a key component of acute sickness behavior and cachexia, yet mechanisms of inflammatory signaling in the central nervous system remain unclear. Previous work from our lab and others showed that while MyD88 is an important inflammatory signaling pathway for sickness behavior, MyD88 knockout (MyD88KO) mice still experience sickness behavior after inflammatory stimuli challenge. We found that after systemic lipopolysaccharide (LPS) challenge, MyD88KO mice showed elevated expression of several cytokine and chemokine genes in the hypothalamus. We therefore assessed the role of an additional inflammatory signaling pathway, TRIF, in acute inflammation (LPS challenge) and in a chronic inflammatory state (cancer cachexia). TRIFKO mice resisted anorexia and weight loss after peripheral (intraperitoneal, IP) or central (intracerebroventricular, ICV) LPS challenge and in a model of pancreatic cancer cachexia. Compared to WT mice, TRIFKO mice showed attenuated upregulation of Il6, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 in the hypothalamus after IP LPS treatment, as well as attenuated microglial activation and neutrophil infiltration into the brain after ICV LPS treatment. Lastly, we found that TRIF was required for Ccl2 upregulation in the hypothalamus and induction of the catabolic genes, Mafbx, Murf1, and Foxo1 in gastrocnemius during pancreatic cancer. In summary, our results show that TRIF is an important inflammatory signaling mediator of sickness behavior and cachexia and presents a novel therapeutic target for these conditions.

Original languageEnglish (US)
JournalBrain, Behavior, and Immunity
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Illness Behavior
Cachexia
Lipopolysaccharides
Hypothalamus
Neoplasms
Pancreatic Neoplasms
Knockout Mice
Up-Regulation
Inflammation
Neutrophil Infiltration
Anorexia
Chemokines
Genes
Weight Loss
Central Nervous System
Cytokines
Brain

Keywords

  • Cachexia
  • Hypothalamus
  • Microglia
  • Neuroimmunology
  • Neuroinflammation
  • Sickness behavior

ASJC Scopus subject areas

  • Immunology
  • Endocrine and Autonomic Systems
  • Behavioral Neuroscience

Cite this

TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia. / Burfeind, Kevin G.; Zhu, Xinxia; Levasseur, Peter R.; Michaelis, Katherine A.; Norgard, Mason A.; Marks, Daniel.

In: Brain, Behavior, and Immunity, 01.01.2018.

Research output: Contribution to journalArticle

Burfeind, Kevin G. ; Zhu, Xinxia ; Levasseur, Peter R. ; Michaelis, Katherine A. ; Norgard, Mason A. ; Marks, Daniel. / TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia. In: Brain, Behavior, and Immunity. 2018.
@article{058a6e8680394b39bb628a83a4b5743c,
title = "TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia",
abstract = "Hypothalamic inflammation is a key component of acute sickness behavior and cachexia, yet mechanisms of inflammatory signaling in the central nervous system remain unclear. Previous work from our lab and others showed that while MyD88 is an important inflammatory signaling pathway for sickness behavior, MyD88 knockout (MyD88KO) mice still experience sickness behavior after inflammatory stimuli challenge. We found that after systemic lipopolysaccharide (LPS) challenge, MyD88KO mice showed elevated expression of several cytokine and chemokine genes in the hypothalamus. We therefore assessed the role of an additional inflammatory signaling pathway, TRIF, in acute inflammation (LPS challenge) and in a chronic inflammatory state (cancer cachexia). TRIFKO mice resisted anorexia and weight loss after peripheral (intraperitoneal, IP) or central (intracerebroventricular, ICV) LPS challenge and in a model of pancreatic cancer cachexia. Compared to WT mice, TRIFKO mice showed attenuated upregulation of Il6, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 in the hypothalamus after IP LPS treatment, as well as attenuated microglial activation and neutrophil infiltration into the brain after ICV LPS treatment. Lastly, we found that TRIF was required for Ccl2 upregulation in the hypothalamus and induction of the catabolic genes, Mafbx, Murf1, and Foxo1 in gastrocnemius during pancreatic cancer. In summary, our results show that TRIF is an important inflammatory signaling mediator of sickness behavior and cachexia and presents a novel therapeutic target for these conditions.",
keywords = "Cachexia, Hypothalamus, Microglia, Neuroimmunology, Neuroinflammation, Sickness behavior",
author = "Burfeind, {Kevin G.} and Xinxia Zhu and Levasseur, {Peter R.} and Michaelis, {Katherine A.} and Norgard, {Mason A.} and Daniel Marks",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.bbi.2018.05.021",
language = "English (US)",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia

AU - Burfeind, Kevin G.

AU - Zhu, Xinxia

AU - Levasseur, Peter R.

AU - Michaelis, Katherine A.

AU - Norgard, Mason A.

AU - Marks, Daniel

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Hypothalamic inflammation is a key component of acute sickness behavior and cachexia, yet mechanisms of inflammatory signaling in the central nervous system remain unclear. Previous work from our lab and others showed that while MyD88 is an important inflammatory signaling pathway for sickness behavior, MyD88 knockout (MyD88KO) mice still experience sickness behavior after inflammatory stimuli challenge. We found that after systemic lipopolysaccharide (LPS) challenge, MyD88KO mice showed elevated expression of several cytokine and chemokine genes in the hypothalamus. We therefore assessed the role of an additional inflammatory signaling pathway, TRIF, in acute inflammation (LPS challenge) and in a chronic inflammatory state (cancer cachexia). TRIFKO mice resisted anorexia and weight loss after peripheral (intraperitoneal, IP) or central (intracerebroventricular, ICV) LPS challenge and in a model of pancreatic cancer cachexia. Compared to WT mice, TRIFKO mice showed attenuated upregulation of Il6, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 in the hypothalamus after IP LPS treatment, as well as attenuated microglial activation and neutrophil infiltration into the brain after ICV LPS treatment. Lastly, we found that TRIF was required for Ccl2 upregulation in the hypothalamus and induction of the catabolic genes, Mafbx, Murf1, and Foxo1 in gastrocnemius during pancreatic cancer. In summary, our results show that TRIF is an important inflammatory signaling mediator of sickness behavior and cachexia and presents a novel therapeutic target for these conditions.

AB - Hypothalamic inflammation is a key component of acute sickness behavior and cachexia, yet mechanisms of inflammatory signaling in the central nervous system remain unclear. Previous work from our lab and others showed that while MyD88 is an important inflammatory signaling pathway for sickness behavior, MyD88 knockout (MyD88KO) mice still experience sickness behavior after inflammatory stimuli challenge. We found that after systemic lipopolysaccharide (LPS) challenge, MyD88KO mice showed elevated expression of several cytokine and chemokine genes in the hypothalamus. We therefore assessed the role of an additional inflammatory signaling pathway, TRIF, in acute inflammation (LPS challenge) and in a chronic inflammatory state (cancer cachexia). TRIFKO mice resisted anorexia and weight loss after peripheral (intraperitoneal, IP) or central (intracerebroventricular, ICV) LPS challenge and in a model of pancreatic cancer cachexia. Compared to WT mice, TRIFKO mice showed attenuated upregulation of Il6, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 in the hypothalamus after IP LPS treatment, as well as attenuated microglial activation and neutrophil infiltration into the brain after ICV LPS treatment. Lastly, we found that TRIF was required for Ccl2 upregulation in the hypothalamus and induction of the catabolic genes, Mafbx, Murf1, and Foxo1 in gastrocnemius during pancreatic cancer. In summary, our results show that TRIF is an important inflammatory signaling mediator of sickness behavior and cachexia and presents a novel therapeutic target for these conditions.

KW - Cachexia

KW - Hypothalamus

KW - Microglia

KW - Neuroimmunology

KW - Neuroinflammation

KW - Sickness behavior

UR - http://www.scopus.com/inward/record.url?scp=85047617980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047617980&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2018.05.021

DO - 10.1016/j.bbi.2018.05.021

M3 - Article

C2 - 29852290

AN - SCOPUS:85047617980

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

ER -